Ovid Therapeutics

Ovid eyes next chapter with CEO transition—Chutes & Ladders

Ovid's Levin set to become chairman as its next CEO stands ready. FDA’s oncology head takes top CDER post. Metagenomi shuffles CEO in reorg. Plus more.

Darren Incorvaia , Zoey Becker Nov 14, 2025 8:30am

Takeda axes epilepsy asset after FDA weighs in on data package

Jan 30, 2025 7:19am

Ovid pauses ph. 2 plans for ROCK2 inhibitor to mull rival's data

Nov 13, 2024 8:15am

An artists rendition of a seizure in the brain The brain is outlined in neon blue with the overactive neurons in glowing r

Ovid halts preclinical work, IV program after soticlestat fail

Aug 13, 2024 9:15am

long shot miss basketball hoop fail shoot

Takeda flunks pivotal epilepsy tests but mulls path to market

Jun 17, 2024 8:50am

cash runway cash airplane extend deal earnings

Ovid sells some royalty rights to Takeda-partnered seizure drug

Oct 18, 2023 8:00am